Cannabidiol—recent advances

Mechoulam, Raphael, Peters, Maximilian, Murillo‐Rodriguez, Eric, Hanuš, Lumír O.·2007·Chemistry & Biodiversity
DOI 10.1002/cbdv.200790147

Cited by (516)

Items 301–400 of 516

  1. Improved Therapeutic Efficacy of CBD with Good Tolerance in the Treatment of Breast Cancer through Nanoencapsulation and in Combination with 20(S)-Protopanaxadiol (PPD)
    Jingxin Fu, Kunfeng Zhang, Likang Lu, Manzhen Li, Meihua Han, Yifei Guo, Xiangtao Wang · 2022 · Pharmaceutics
  2. Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus
    Asmat Ullah Khan, Luiz Luciano Falconi‐Sobrinho, Tayllon dos Anjos‐Garcia, Maria de Fátima dos Santos Sampaio, José Alexandre S. Crippa, Leda Menescal-de-Oliveira, Norberto Cysne Coimbra · 2020 · Psychopharmacology
  3. High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells
    Francesca Garofano, Ingo G.H. Schmidt‐Wolf · 2020 · International Journal of Molecular Sciences
  4. Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders
    Natasha Beukes, Ruby‐Ann Levendal, Carminita Lara Frost · 2014 · Journal of Pharmacy and Pharmacology
  5. Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis
    Roberto Chiocchetti, Margherita De Silva, Francesca Aspidi, Rodrigo Zamith Cunha, Francesca Gobbo, Claudio Tagliavia, Giuseppe Sarli, Maria Morini · 2022 · Frontiers in Veterinary Science
  6. Chloro aluminum phthalocyanine-based organic thin-film transistors as cannabinoid sensors: engineering the thin film response
    Halynne R. Lamontagne, Zachary J. Comeau, Rosemary R. Cranston, Nicholas T. Boileau, Cory S. Harris, Adam J. Shuhendler, Benoit Hugo Lessard · 2022 · Sensors & Diagnostics
  7. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
    Cecilia Zavala‐Tecuapetla, Hiram Luna‐Munguía, María Leonor López‐Meraz, Manola Cuéllar‐Herrera · 2022 · International Journal of Molecular Sciences
  8. Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment
    Rebeca Pérez, Talita Glaser, Cecilia Villegas, Viviana Burgos, Henning Ulrich, Cristian Paz · 2022 · Life
  9. Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
    Radu Tănăsescu, Cris S. Constantinescu · 2013 · Expert Opinion on Drug Metabolism & Toxicology
  10. Real-Time Monitoring of the Cytotoxic and Antimetastatic Properties of Cannabidiol in Human Oral Squamous Cell Carcinoma Cells Using Electric Cell-Substrate Impedance Sensing
    Chien-Chu Huang, Shao‐Chih Chiu, Shao‐Chih Chiu, Heng-Yi Liao, Shiao‐Pieng Lee, Chun-Chung Huang, Der‐Yang Cho · 2022 · International Journal of Molecular Sciences
  11. Cannabis and psychopathology: The meandering journey of the last decade
    Debasish Basu, Abhishek Ghosh · 2015 · Indian Journal of Psychiatry
  12. The Role of Cannabis and Cannabinoids in Diabetes
    Martin Frisher, Simon J. White, Gábor Várbiró, Carolyn Voisey, Dhaya Perumal, ILANA B. CROME, Nazmeen Khideja, James Bashford · 2010 · The British Journal of Diabetes
  13. Cannabidiol—A friend or a foe?
    Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, Daniel Gună, Ciprian Iliescu, Mariana Carmen Chifiriuc · 2025 · European Journal of Pharmaceutical Sciences
  14. Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?
    Sara N. Davison, Joseph S. Davison · 2011 · Journal of Pain and Symptom Management
  15. An Overview of Galenic Preparation Methods for Medicinal Cannabis
    Luigi L Romano, Arno Hazekamp · 2018 · Current Bioactive Compounds
  16. Genome-Wide Analysis of Alternative Splicing and Non-Coding RNAs Reveal Complicated Transcriptional Regulation in Cannabis sativa L.
    Bin Wu, Yanni Li, Jishuang Li, Zhenzhen Xie, Mingbao Luan, Chunsheng Gao, Yuhua Shi, Shilin Chen · 2021 · International Journal of Molecular Sciences
  17. Medicinal Use of Synthetic Cannabinoids—a Mini Review
    P. Muralidhar Reddy, Nancy Maurya, Bharath Kumar Velmurugan · 2019 · Current Pharmacology Reports
  18. Electrochemical Assessment of Anticancer Compounds on the Human Tongue Squamous Carcinoma Cells
    Chun-Chung Huang, Tse-Hua Tung, Chien-Chu Huang, Shao-Yi Lin, Shih‐Chi Chao, Sheng-Po Chiu, Shiao‐Pieng Lee, Chun‐Min Lo · 2020 · Sensors
  19. Localisation of Cannabinoid and Cannabinoid-Related Receptors in the Horse Ileum
    Giorgia Galiazzo, Claudio Tagliavia, Fiorella Giancola, Riccardo Rinnovati, Javad Sadeghinezhad, Cristiano Bombardi, Annamaria Grandis, Marco Pietra, Roberto Chiocchetti · 2021 · Journal of Equine Veterinary Science
  20. Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein
    Maria F. Fernandes, John Zewen Chan, Chia Chun Joey Hung, Michelle Victoria Tomczewski, Robin E. Duncan · 2022 · Life Sciences
  21. GSH-AuNCs@ZIF-8 as chemiluminescence imaging label for high-throughput and ultrasensitive detection of THC and THC-COOH
    Zuhao Zhang, Yi Dai, Xuan Zhang, Jun-Ming Li, Hua Qiang Yang, Chen Zong, Wen Yuan Gao · 2024 · Sensors and Actuators B Chemical
  22. Cannabidiol Partially Blocks the Excessive Sleepiness in Hypocretindeficient Rats: Preliminary Data
    Eric Murillo‐Rodríguez, Diana Millán‐Aldaco, Marcela Palomero‐Rivero, Daniela Morales-Lara, Raphael Mechoulam, René Drucker-Colı́n · 2019 · CNS & Neurological Disorders - Drug Targets
  23. Cannabidiol Interferes with Establishment of Δ 9 -Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism
    Marieka V. DeVuono, Olivia La Caprara, Gavin N. Petrie, Cheryl L. Limebeer, Erin M. Rock, Matthew N. Hill, Linda A. Parker · 2020 · Cannabis and Cannabinoid Research
  24. Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol
    Mohammad‐Reza Ghovanloo, Sulayman D. Dib‐Hajj, Samuel J. Goodchild, Peter C. Ruben, Stephen G. Waxman · 2022 · Frontiers in Physiology
  25. Should oncologists trust cannabinoids?
    Ioana Creangă-Murariu, Leontina-Elena Filipiuc, Magdalena D. Cuciureanu, Bogdan-Ionel Tamba, Teodora Alexa‐Stratulat · 2023 · Frontiers in Pharmacology
  26. Functionally-selective inhibition of threshold sodium currents and excitability in dorsal root ganglion neurons by cannabinol
    Mohammad-Reza Ghovanloo, Philip R. Effraim, Sidharth Tyagi, Peng Zhao, S. Dib-Hajj, S. Waxman · 2024 · Communications Biology
  27. The Efficacy of Cannabis in Oncology Patient Care and Its Anti-Tumor Effects
    Walid Shalata, Omar Abu Saleh, Lena Tourkey, Sondos Shalata, Ala Eddin Neime, Ali Abu‐Juma, Arina Soklakova, Lama Tourkey, Ashraf Abu Jama, Alexander Yakobson · 2024 · Cancers
  28. Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
    Balapal S. Basavarajappa, Shivakumar Subbanna · 2024 · Biomolecules
  29. Review Article: Sleep, Pain and Cannabis
    Ferguson G Ware · 2015 · Journal of Sleep Disorders & Therapy
  30. Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models
    Paula Morales, Patricia H. Reggio · 2020 · Advances in experimental medicine and biology
  31. Pharmacological and Pharmacokinetic Profile of Cannabidiol in Human Epilepsy: A Review of Metabolism, Therapeutic Drug Monitoring, and Interactions with Antiseizure Medications
    Jihoon Na, Young‐Mock Lee · 2025 · Biomolecules
  32. Optimization of Pulsed Electric Field-Based Extraction of Bioactive Compounds from Cannabis sativa Leaves
    Dimitrios Mpakos, Theodoros G. Chatzimitakos, Vassilis Athanasiadis, Martha Mantiniotou, Eleni Bozinou, Stavros I. Lalas · 2024 · Analytica—A Journal of Analytical Chemistry and Chemical Analysis
  33. The effects of cannabidiol against Methotrexate‐induced lung damage
    Özlem Özmen, Adem Milletsever, Şerife Taşan, Esma Selçuk, Mehtap Savran · 2024 · Basic & Clinical Pharmacology & Toxicology
  34. Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies
    Natasha Irrera, Alessandra Bitto, Emanuela Sant’Antonio, Rita Lauro, Caterina Musolino, Alessandro Allegra · 2021 · Molecules
  35. Genotoxicity evaluation of cannabidiol
    Rayetta G. Henderson, Brian T. Welsh, Kristen R. Trexler, Marcel O. Bonn‐Miller, Timothy W. Lefever · 2023 · Regulatory Toxicology and Pharmacology
  36. Mães pela cannabis medicinal em um Brasil aterrorizado entre luzes e fantasmas
    Virgínia Martins Carvalho, Margarete Santos de Brito, Mário Gandra · 2017 · Forum Sociológico
  37. Journal of Sleep Disorders & Therapy
    2020
  38. Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism
    Douglas Lamounier de Almeida, Renata Cristina Mendes Ferreira, Flávia Cristina de Sousa Fonseca, Daniel Portela Dias Machado, Danielle Diniz Aguiar, Francisco Silveira Guimarães, Igor Dimitri Gama Duarte, Thiago Roberto Lima Romero · 2024 · Nitric Oxide
  39. The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial
    Tristan P. Hurzeler, Warren Logge, Joshua Watt, Marilena M. DeMayo, Anastasia S. Suraev, Iain S. McGregor, Paul Haber, Kirsten C. Morley · 2024 · Contemporary Clinical Trials Communications
  40. Cannabinoids from C. sativa L.: Systematic Review on Potential Pharmacological Effects against Infectious Diseases Downstream and Multidrug-Resistant Pathogens
    Adriana C. Ribeiro, Rahaf Alsayyed, Daniele Martins de Lima Oliveira, Rui Loureiro, Helena Maria Cabral-Marques · 2024 · Future Pharmacology
  41. Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications
    Elise A. Schubert, Jan‐Willem C. Alffenaar, Masego T Johnstone, John W Barlow, Nial Wheate · 2022 · International Journal of Pharmacy Practice
  42. Synthesis of (−)‐Cannabidiol (CBD), (−)‐Δ9‐ and (−)‐Δ8‐Tetrahydrocannabinols, Encapsulation of CBD with Nanoparticles for Controlled Delivery and Biological Evaluation
    Federico Moya‐Utrera, David Fuentes‐Ríos, Antonio Romero‐Carrasco, Manuel Doña‐Flores, Iván Cheng‐Sánchez, Amelia Díaz, María Soledad Pino-González, Antonio Martinez-Ferez, Javier Moreno, Cristina Mesas et al. · 2024 · Chemistry - A European Journal
  43. Cannabidiol mitigates methotrexate-induced hepatic injury via SIRT-1/p53 signaling and mitochondrial pathways: reduces oxidative stress and inflammation
    İlter İlhan, Halil Aşçı, İbrahim Aydın Candan, Mehtap Savran, Orhan Berk İmeci, Mehmet Abdulkadir Sevük · 2024 · Drug and Chemical Toxicology
  44. Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB1 and CB2 Receptors
    Alexander J. Hamilton, Alan D. Payne, Mauro Mocerino, Hendra Gunosewoyo · 2021 · Australian Journal of Chemistry
  45. Effects of Co‐occurring marijuana use and anxiety on brain structure and functioning: A systematic review of adolescent studies
    Mary Kathryn Cancilliere, Miryam Yusufov, Lisa L. Weyandt · 2018 · Journal of Adolescence
  46. Association between self-reported marijuana use and incident diabetes in women and men with and at risk for HIV
    Chukwuemeka N. Okafor, M. Plankey, David Goodman-Meza, Michael J. Li, Karla J. Bautista, H. Bolivar, Tien C Phyllis, T. Brown, S. Shoptaw · 2020 · Drug and Alcohol Dependence
  47. Recent Progress in the Drug Development for the Treatment of Alzheimer’s Disease Especially on Inhibition of Amyloid-peptide Aggregation
    Yuanyuan Liu, Lin Cong, Chu Han, Bo Li, Rongji Dai · 2020 · Mini-Reviews in Medicinal Chemistry
  48. Safety of cannabis- and hemp-derived constituents in reproduction and development
    J. Akingbasote, Sandra K. Szlapinski, Andrew Charrette, C. Hilmas, N. Guthrie · 2022 · Reproductive and Developmental Toxicology
  49. The Endocannabinoid System in Prefrontal Synaptopathies
    Andrew F. Scheyer, Henry G. S. Martin, Olivier J. Manzoni · 2017 · Springer eBooks
  50. Effect of Cannabidiol in LPS-Induced Toxicity in Astrocytes: Possible Role for Cannabinoid Type-1 Receptors
    Hind Ibork, Sara El Idrissi, Simo S. Zulu, Robert G. Miller, Lhoussain Hajji, Annabelle Manalo Morgan, Khalid Taghzouti, Oualid Abboussi · 2023 · Neurotoxicity Research
  51. Enhancing Cannabinoid Bioavailability in Pain Management: The Role of Cyclodextrins
    Adriana C. Ribeiro, Rui Loureiro, Helena Maria Cabral-Marques · 2024 · Molecules
  52. Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility
    Patrycja Kalak, Piotr Kupczyk, Antoni Jacek Szumny, Tomasz Gębarowski, Marcin Jasiak, А. Niedźwiedź, Wojciech Niżański, Michał Dzięcioł · 2025 · International Journal of Molecular Sciences
  53. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
    Ahmet Onay, Abdülselam Ertaş, Veysel Süzerer, İsmail Yener, Mustafa Abdullah Yılmaz, Emine Ayaz Tilkat, Remzi Ekıncı, Nesrin Bozhan, Sevgi İrtegün Kandemir · 2021 · TURKISH JOURNAL OF BIOLOGY
  54. Women are taking the hit: Examining the unique consequences of cannabis use across the female lifespan
    Erin L. Gräfe, Hannah M. O. Reid, Irene Shkolnikov, K. Conway, Ah Kit, C. Acosta, Brian R. Christie · 2023 · Frontiers in Neuroendocrinology
  55. Pipeline for High-Throughput Modeling of Marijuana and Hemp Extracts
    Zewei Chen, Peter de B. Harrington · 2019 · Analytical Chemistry
  56. Consommation de cannabis: quels sont les risques ?
    Christian Giroud, Marc Daniel Bollmann, Aurélien Thomas, Patrice J. Mangin, Bernard Favrat · 2008 · Annales de Toxicologie Analytique
  57. Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid β-peptide25–35
    Karen del Carmen Barboza Salgado, Rosiene Gomes de Freitas Nascimento, Pedro José Fernandes Nunes Coelho, Laser Antônio Machado Oliveira, Katiane de Oliveira Pinto Coelho Nogueira · 2024 · Toxicology in Vitro
  58. Cholestasis impaired spatial and non-spatial novelty detection in mice
    Maryam Nasehi, Saeed Hesami Tackallou, Iman Hasani, Mohammad Nasehi · 2013 · Archives of Advances in Biosciences
  59. Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion
    Melanie B. Elliott, Sara Jane Ward, Mary E. Abood, Ronald F. Tuma, Jack Jallo · 2017 · Concussion
  60. Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials
    Tara Rosewall, Carina Nicole Feuz, Andrew Bayley · 2020 · Journal of medical imaging and radiation sciences
  61. Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids
    Katarína Kosalková, Carlos Barreiro, Isabel-Clara Sánchez-Orejas, Laura Cueto, Carlos García‐Estrada · 2023 · Journal of Fungi
  62. Standardized natural product cannabis in pain management and observations at a Canadian compassion society: a case report
    Alison Hornby, Manju Sharma, Bree Stegman · 2009 · Cases Journal
  63. Cannabidiol and Neuroprotection: Evidence from Preclinical Studies
    Nadja Schröder, V.K. da Silva, Jaime E. C. Hallak, Antônio Waldo Zuardi, José Alexandre S. Crippa · 2017 · Elsevier eBooks
  64. New Polymeric Hydrogels with Cannabidiol and α-Terpineol as Potential Materials for Skin Regeneration—Synthesis and Physicochemical and Biological Characterization
    Martyna Zagórska-Dziok, Anna Nowak, Anna Zgadzaj, Ewa Olędzka, Karolina Kędra-Królik, Agnieszka Ewa Wiącek, Marcin Sobczak · 2024 · International Journal of Molecular Sciences
  65. Medicinal cannabis for Australian patients with chronic refractory pain including arthritis
    Elise A. Schubert, Masego T Johnstone, Melissa J. Benson, Jan‐Willem C. Alffenaar, Nial Wheate · 2022 · British Journal of Pain
  66. Could cannabinoids provide a new hope for ovarian cancer patients?
    Rimanee Kaur, Farideh A. Javid · 2023 · Pharmacology Research & Perspectives
  67. Cannabinoid Signaling Through Non-CB1R/Non-CB2R Targets in Microglia
    Neta Rimmerman, Ewa Kozela, Rivka Levy, Zvi Vogel, Ana Juknat · 2012 · The Receptors
  68. A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors
    Eduardo Rodriguez Almaraz, Susan Marina Chang, Jennifer Leigh Clarke, Nancy Ann Oberheim-Bush, Jennie Webster Taylor, Robin Arthur Buerki, Mitchel Stuart Berger, Lydia B. Zablotska, Iryna V. Lobach, Nicholas Arthur Butowski · 2020 · Neuro-Oncology Practice
  69. Endocannabinoids and epilepsy
    Robert E. Blair, Laxmikant S. Deshpande, Robert John DeLorenzo · 2015 · Elsevier eBooks
  70. Medical cannabis: time for clear thinking
    David G. Penington · 2015 · The Medical Journal of Australia
  71. High-Throughput Chemotyping of Cannabis and Hemp Extracts Using an Ultraviolet Microplate Reader and Multivariate Classifiers
    Zewei Chen, Peter de B. Harrington, Steven F. Baugh · 2018 · Journal of Analysis and Testing
  72. A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’
    Radu Tănăsescu, David J. Rog, Cris S. Constantinescu · 2011 · Expert Opinion on Drug Discovery
  73. Perceptual Drug Discriminative Aspects of the Endocannabinoid Signaling System in Animals And Man
    Torbjörn U.C. Järbe · 2011 · Wiley eBooks
  74. A Chemo-Enzymatic Platform for Furanolide Synthesis and Functional Exploration
    Xiaoqi Ji, Manuel Einsiedler, Paul M. D’Agostino, Jennifer E. Herrmann, Rolf Müller, Tobias A. M. Gulder · 2025 · Journal of the American Chemical Society
  75. Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review
    Tristan P. Hurzeler, Joshua Watt, Warren Logge, Ellen E Towers, Anastasia S. Suraev, Nicholas Lintzeris, Paul Haber, Kirsten C. Morley · 2024 · Journal of Cannabis Research
  76. FDA-approved cannabidiol [Epidiolex®] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis
    Maheedhar Kodali, Leelavathi Narayana Madhu, Venkata Sai Vashishta Kolla, Sahithi Attaluri, Charles Huard, Yogish Somayaji, Bing Shuai, Chase Jordan, Xiaolan Rao, Sanath Shetty et al. · 2024 · Military Medical Research
  77. Contribution à une exploration des propriétés thérapeutiques du cannabis
    Ingold Fr, Christian Sueur, Charles D. Kaplan · 2015 · Annales Médico-psychologiques revue psychiatrique
  78. Effects of Marijuana Use in Patients with Orthopaedic Trauma
    Sean G. Sheppard, Pelle V. Wall, Benjamin Wheatley, William T. Kent · 2021 · JBJS Reviews
  79. The effects of cannabidiol on behavioural and oxidative stress parameters induced by prolonged haloperidol administration
    Jaiyeola Abiola Kajero, Soraya Seedat, JUDE UZOMA OHAERI, Abidemi James Akindele, Oluwagbemiga Olanrewaju Aina · 2022 · Acta Neuropsychiatrica
  80. A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2
    Neda Tadayon, Ali Ramazani · 2021 · Journal of the Iranian Chemical Society
  81. Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
    Ahmed Hasbi, Susan R. George · 2025 · Exploration of Neuroprotective Therapy
  82. Profiling Allosteric Modulators of CB 1 R with an Allosteric Fluoroprobe
    Miroslav Kosar, Themiya Perera, Rudolf L. Z. Ganzoni, Roman C. Sarott, Leire Borrega‐Roman, Rosa Maria Vitale, Alessia Ligresti, Arne Christian Rufer, Wolfgang Guba, Uwe Grether et al. · 2025 · Angewandte Chemie International Edition
  83. Cholestasis and behavioral disorders.
    Delaram Eslimi Esfahani, Mohammad‐Reza Zarrindast · 2021 · Gastroenterology and hepatology from bed to bench.
  84. Hemp essential oil: an innovative product with potential industrial applications
    Eugenia Mazzara, Riccardo Petrelli, Jacopo Torresi, Renato Ricciardi, Giovanni Benelli, Filippo Maggi · 2022 · Elsevier eBooks
  85. Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration
    Miriam Sciaccaluga, Gabriele Ruffolo, Eleonora Palma, Cinzia Costa · 2023 · Current Neuropharmacology
  86. Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol
    Ehud Ziv, Lola Weiss, Raz Itamar, Natan Patlas, Zhanna Yekhtin, Ruth Gallily · 2012 · Journal of Diabetes Mellitus
  87. Research Advances in Cannabinoids of Cannabis sativa
    Xuan Chen, Yang Ming, Guo Hongyan · 2011 · Chinese Bulletin of Botany
  88. Marijuana not ready for prime time as an analgesic
    Andrew J. Saxon, Kendall W. Browne · 2013 · General Hospital Psychiatry
  89. Fifty years of ‘cannabinoid research’ and the need for a new nomenclature
    Vincenzo Di Marzo, Luciano De PETROCELLIS · 2014
  90. Cannabidiol improves L-DOPA-induced dyskinesia and modulates neuroinflammation and the endocannabinoid, endovanilloid and nitrergic systems
    Glauce Crivelaro Nascimento, Gabriela Gonçalves Bálico, Bianca Andretto de Mattos, Maurício dos Santos Pereira, Igor Gustavo Carvalho Oliveira, Maria Eugênia Costa Queiroz, Lilian Carmo Heck, Luiz Carlos Carvalho Navegantes, Francisco Silveira Guimarães, Elaine Del-Bel · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  91. Cannabidiol as a candidate pharmacotherapy for sleep disturbance in alcohol use disorder
    Marie N. S. Gendy, Benicio Noronha Frey, Michael Van Ameringen, Nirushi Kuhathasan, James M. MacKillop · 2023 · Alcohol and Alcoholism
  92. Are cannabidiol (CBD) levels in consumer food products well tested?—A review
    Shahida Anusha Siddiqui, Hafize Fidan, Stanko Stankov, Mohammad Mehdizadeh, Tigran Garrievich Ambartsumov, Mohammad Kharazmi, Shubhra Singh, Seid Mahdi Jafari · 2023 · Food Frontiers
  93. New Analytical Screening Method for Fast Classification of Hemp Oil Based on THC Content
    Thaineh E. A. Souza, Gustavo Bertol, Poliana Macedo dos Santos · 2025 · ACS Omega
  94. CB2 receptor as a potential target in age-related diseases
    Anu Kauppinen, Tapio Nevalainen, Maria Hytti, Antero Salminen, Teija Parkkari · 2014
  95. Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
    Valentina F. Kitchigina · 2021 · Neuroscience and Behavioral Physiology
  96. Propylene glycol and Kolliphor as solvents for systemic delivery of cannabinoids via intraperitoneal and subcutaneous routes in preclinical studies: a comparative technical note
    Kaveh Momenzadeh, Diana Yeritsyan, Nadim Kheir, Rosalynn M. Nazarian, Ara Nazarian · 2023 · Journal of Cannabis Research
  97. Pharmacological Tools in Endocannabinoid Neurobiology
    Marco Mor, Alessio Lodola · 2009 · Current topics in behavioral neurosciences
  98. Cannabidiol and Multiple Sclerosis
    Míriam Mecha, Ana Feliú, Francisco Javier Carrillo-Salinas, Carmen Guaza · 2017 · Elsevier eBooks
  99. Characterisation of components of an extract of hemp and preliminary assessment of anti-inflammatory activity in an ex vivo model of bovine endometritis
    Ifat Parveen, Nathan R. Allen, Ruth E. Wonfor, Ammar A. Al-Fadhli, Josephine Forde-Thomas, Joanna L. Giles, Robert T. Walton, Michael D. Threadgill, Deborah M. Nash · 2025 · South African Journal of Botany
  100. Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (−) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives
    Santiago Rodríguez-Carreiro, María Gómez‐Cañas, Francesca Lubrini, Claudia Gonzalo‐Consuegra, Matthias Winkler, Diego Caprioglio, Giovanni Appendino, Concepción García, Paula Morales, Nadine Jagerovic et al. · 2025 · European Journal of Medicinal Chemistry Reports